Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
392M
-
Number of holders
-
868
-
Total 13F shares, excl. options
-
352M
-
Shares change
-
-23.1M
-
Total reported value, excl. options
-
$23.6B
-
Value change
-
-$2.16B
-
Put/Call ratio
-
1.04
-
Number of buys
-
408
-
Number of sells
-
-535
-
Price
-
$67.04
Significant Holders of DEXCOM INC - Common Stock (DXCM) as of Q3 2024
1,136 filings reported holding DXCM - DEXCOM INC - Common Stock as of Q3 2024.
DEXCOM INC - Common Stock (DXCM) has 868 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 352M shares
of 392M outstanding shares and own 89.86% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (47.4M shares), BlackRock, Inc. (35M shares), Capital Research Global Investors (17.9M shares), STATE STREET CORP (16.7M shares), BAILLIE GIFFORD & CO (15M shares), SANDS CAPITAL MANAGEMENT, LLC (10.3M shares), GEODE CAPITAL MANAGEMENT, LLC (9.94M shares), Nuveen Asset Management, LLC (8.09M shares), Capital World Investors (7.63M shares), and JENNISON ASSOCIATES LLC (6.93M shares).
This table shows the top 868 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.